Acupuncture for type 2 diabetes

Acupuncture for type 2 diabetes
reference
Kumar R., Mooventhan A., Manjunath NK. Direct effect of the needle at the acupuncture point CV-12 (Zhongwan) on blood sugar levels in patients with type 2 diabetes mellitus: a randomized placebo-controlled pilot study. J acupuncture meridian stud . 2017: 19 (4): 240-244.
Study goal
The effect of the needle at CV-12 on random blood sugar levels (RBG) should be examined in men with type 2 diabetes (T2D).
draft
pilot study, randomized, placebo -controlled study.
participant
Forty men with T2D aged 56.2 ± 11.0 years, who take their medication stable in the past 3 months, have been allocated either the treatment group (n = 20) or the placebo group (n = 20). The 2 groups were similar in age, gender, size, weight and body mass index (BMI). The exclusion criteria included T2D complications in anamnesis, needle phobia and mental illnesses.
primary result measurements
Random blood sugar before and after treatment with a portable Accu-Chek Active, Performa Nano device from Roche Diagnostics, Mumbai, India.
Intervention
The participants of the treatment group were gifted at CV-12 4 CUN (4 times as wide as the thumb of a person on the ankle) above the middle of the nabel for 30 minutes up to a depth of 0.5 cun with a locally produced 0.5 cun filiform-cup pawl 0.38 mm diameter at a length of 13 mm. The participants of the placebo group were grown with the same needle type in 1 cun lateral from CV-12 for 30 minutes, where there is no known acupuncture point. Manual stimulation, known as a bird picking, the needle was moved up and down was carried out in each group for 5 minutes.
important knowledge
Compared to the control group, RBG was somewhat higher in the treatment group at the beginning of the course (146.1 vs. 139.15 mg/dl) and a little lower after acupuncture (133.85 vs. 138.8 mg/dl). The change in the RBG compared to the initial value according to acupuncture (146.1 vs. 133.85 mg/dl) was significant in the treatment group ( p <0.001), but not in the placebo group. There was no significant difference between the two groups in the RGB change compared to the initial value according to acupuncture.
practice implications
The impetus for the present study was a attempt to electronically custody in 1999 in diabetic rats. This study came to the conclusion that the secretion of endogenous beta endorphin, depending on 30 minutes of electrical acupuncture at CV-12 in normal rats and rats, reduced the secretion with T2D, but not for rats with type 1 diabetes, which was induced by streptozotocin or genetics. 1 Blood -lowering effect was canceled by naloxone in a dose that is sufficient to block the opioid receptors and not supported by glucagon.
Mohanti et al. The first most human study from 1999 to 36 volunteers who received an acupuncture for 20 minutes without stimulation either on CV-12 or at the above point. 2 There was a slight decrease in RBG in the treatment group and a slight increase in RBG in the placebo or bogus treatment group, but the results were statistically not significant. The same 3 researchers then carried out the present study and published them.
acupuncture can lower blood sugar if the correct person is/are the right person, but the durability of the lowered blood sugar must still be demonstrated in a clinical study.
in a study that shortly before the 2016 study by Mohanti et al. Researched acupuncture at CV-12, C-10, C-4, C-4, ST-24, TW-5, ST-25, SP-15. and Ki-13 three times a week for 3 weeks with 30 obese participants with T2D and compared their reactions with 30 similar patients (obesity with T2D) who only revenue. 3 in the acupuncture group were systolic blood pressure, waist circumference, BMI, sober-blood sugar, 2-hour glucose tolerance test, sober insulin, soberin, sober. Total cholesterol and low-density lipoprotein (LDL) cholesterol significantly reduced ( p <0.05). The overall response rate was 93 % (28/30) in the acupuncture group and 23 % (7/30) in the group with pure medication, a significant difference ( p <0.01). They did not report whether the effect was sustainable.
Other recent studies support the advantages of acupuncture for glucose control in humans. A study published in 2014 comprised 99 obese women with a risk of diabetes. 4 They were dealt with with acupuncture, moxibustion, electrical acupuncture and combinations of the 3 and had a significant reduction in body weight ( p <0.001), BMI ( p <0.001), insulin ( p <0.01) and insulin resistance index ( p <0.01) compared to appearance. So there was a significant reduction in her overall risk of developing diabetes.
A research report published in 2010 came to the conclusion that there is indications that acupuncture improves insulin resistance. 5 A large part of the data came from animals, but there were some test data on humans. The authors called for studies to determine the feasibility of acupuncture as an effective treatment of diabetes.
CV-12 ( Zhongwan ) lies on the meridian of the conception. Digestive problems such as pain, flatulence, reflux, vomiting, diarrhea, jaundice; Digestive problems in connection with a nervous stomach such as fear, insomnia, rethinking and worries; And problems related to the esophagus. CV-12 is also the front MU point for the spleen. From a chakra perspective, CV-12 is the solar plexus chakra and stands for self-confidence and control over your life. 7 In patients with needle phobia, CV-12 can be treated with moxibustion.
summary
In 2014, the World Health Organization estimated that 422 million adults or 8.5 % of the adult population were affected by diabetes worldwide. 8 In North America, the current incidence is 1 out of 10 adults, whereby this number will probably be between 1 out of 3 and 1 out of 5. In the present study, acupuncture RBG reduced significantly in men with diabetes compared to bogus acupuncture. It does not reduce RBG to non -diabetic values and its permanent effect was not assessed. Acupuncture can reduce blood sugar if the correct person (s) is/are in the right person, but the durability of the reduced blood sugar still has to be demonstrated in a clinical study. 3-5 Clinical acupuncture can be part of a more comprehensive treatment protocol to treat type 2 diabetes, but it has not been proven that they have not Diabetes is.
Study restrictions
The restrictions found by the authors include their small sample size, the inclusion of only male patients, the failure, long -term effects, and the measurement of only RBG (vs. sober glucose, postprandial glucose, hemoglobin a
- Chang Sl, Lin Jg, Chi TC, Liu im, Cheng jt. An insulin -dependent hypoglycaemia induced by electrical acupuncture on the Zhongwan (CV12) acupuncture in diabetic rats. diabetology . 1999; 42 (2): 250-255.
- Mohanty S, Mooventhan A, Manjunath NK. Effect of the needle at CV-12 (Zhongwan) on blood sugar in healthy volunteers: a randomized placebo-controlled pilot study. J acupuncture meridian stud . 2016; 9 (6): 307-310.
- yang y, Liu Y. Bos BauchaKupunste with overweight type 2 diabetes mellitus [in Chinese]. zhongguo zhen jiu . 2015; 35 (4): 330-334.
- Garcia-Vivas JM, Galaviz-Hemandez C, Becerril-Chavez f, et al. The acupuncture point catwood inlet therapy with moxibustion reduces the risk of diabetes in obese women. j. Res. Med. Sci . 2014; 19 (7): 610-616.
- Liang fi, Koya D. Acupuncture: Is it effective for the treatment of insulin resistance? diabetes obesity metab . 2010; 12 (7): 555-569.
- Yin Yang House Media Services Group. CV 12 acupuncture point Zhong Wan. https://theory.yinyanghouse.com/acupuncturepoints/cv12. Accessed on January 12, 2018.
- Larsen A. Acupuncture point: concentration vessel 12. (Link removed). Published in January 2018. Access on January 12, 2018.
- World Health Organization. Global report on diabetes. (Link away). Accessed on January 25, 2018.